DSEN Funding

The Drug Safety and Effectiveness Network (DSEN) funds health research in order to develop and support a well-trained base of investigators with the skills and expertise needed to design and conduct innovative and diverse research and knowledge translation activities aimed at improving health.

2015 Funding Decisions

Funding Opportunity Competition Funding Decision
New Investigator Salary Award : Winter 2015 Priority Announcement (Specific Research Areas) 201512MSH View
Other : Rapid Funding for DSEN Targeted Research – 2015-2016
  1. Canadian Early Arthritis Cohort (CATCH)
  2. The National Canadian Research and Training Program in Hepatitis C (NCRTP-HepC)
  3. Pharmacoepidemiology in Multiple Sclerosis Research Group (PMSRG)
  4. GENdEr and Sex DetermInantS of Cardiovascular Disease (GENESIS-PRAXY)
201511DES View
  1. Access to Electronic Medical Record (EMR) data for CNODES studies of drug effects and as a platform for pragmatic trials.
  2. Clinical and pharmacogenomic predictors of inter-patient variation in direct acting oral anticoagulant (DOAC) plasma concentrations in real-world patients.
  3. Inter-patient variation in direct acting oral anticoagulant (DOAC) plasma concentrations in real-world patients, an active surveillance study.
201510DES View
Training Grant: DSEN Training Grant 201508DSN View
Other: Rapid Funding for DSEN Targeted Research – 2014-2015 201503DEC View
Catalyst Grant: Methods in Post-Market Drug Safety and Effectiveness Research
Methods in Post-Market Drug Safety and Effectiveness Research - Bayesian methods and statistical models 201501MP3 View
Methods in Post-Market Drug Safety and Effectiveness Research - Direct patient reporting of post-market outcomes 201501MP2 View
Methods in Post-Market Drug Safety and Effectiveness Research - Registry-randomized trials 201501MP1 View
Date modified: